MOSCOW (Reuters) - Morocco and Kenya have approved Russia’s Sputnik V vaccine for use against the new coronavirus, Russia’s RDIF sovereign wealth fund said on Wednesday.
The fund, which is promoting the vaccine globally, said that 48 countries had now approved Sputnik V for use.
Reporting by Maria Kiselyova, Polina Nikolskaya, Gleb Stolyarov; Writing by Tom Balmforth; Editing by Maria Kiselyova and Alison Williams
Our Standards: The Thomson Reuters Trust Principles.